miR-374a-5p regulates inflammatory genes and monocyte function in patients with inflammatory bowel disease.
View / Open Files
Authors
Publication Date
2022-04-01Journal Title
The Journal of experimental medicine
ISSN
0022-1007
Volume
219
Issue
5
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Perez-Sanchez, C., Barbera Betancourt, A., Lyons, P. A., Zhang, Z., Suo, C., Lee, J. C., McKinney, E. F., et al. (2022). miR-374a-5p regulates inflammatory genes and monocyte function in patients with inflammatory bowel disease.. The Journal of experimental medicine, 219 (5) https://doi.org/10.1084/jem.20211366
Description
Funder: UK National Institute of Health Research Cambridge Biomedical Research Centre
Abstract
MicroRNAs are critical regulators of gene expression controlling cellular processes including inflammation. We explored their role in the pathogenesis of inflammatory bowel disease (IBD) and identified reduced expression of miR-374a-5p in IBD monocytes that correlated with a module of up-regulated genes related to the inflammatory response. Key proinflammatory module genes, including for example TNFα, IL1A, IL6, and OSM, were inversely correlated with miR-374a-5p and were validated in vitro. In colonic biopsies, miR-374a-5p was again reduced in expression and inversely correlated with the same inflammatory module, and its levels predicted subsequent response to anti-TNF therapy. Increased miR-374a-5p expression was shown to control macrophage-driven inflammation by suppressing proinflammatory mediators and to reduce the capacity of monocytes to migrate and activate T cells. Our findings suggest that miR-374a-5p reduction is a central driver of inflammation in IBD, and its therapeutic supplementation could reduce monocyte-driven inflammation in IBD or other immune-mediated diseases.
Keywords
Monocytes, Humans, Colitis, Inflammatory Bowel Diseases, MicroRNAs, Tumor Necrosis Factor Inhibitors
Sponsorship
Wellcome Trust (094227/Z/10/Z, 200871/Z/16/Z)
European Union H2020 project (733100)
Medical Research Council (MR/L019027)
GSK/Cambridge Strategic Alliance Varsity Funding Program (200871/Z/16/Z, 094227/Z/10/Z)
Identifiers
35363256, PMC8980842
External DOI: https://doi.org/10.1084/jem.20211366
This record's URL: https://www.repository.cam.ac.uk/handle/1810/336820
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.